Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
1.020
+0.070 (7.36%)
At close: Apr 1, 2025, 4:00 PM
1.000
-0.020 (-1.96%)
After-hours: Apr 1, 2025, 4:17 PM EDT

Plus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
3578111610
Upgrade
Market Cap Growth
-14.33%-14.33%-25.69%-33.96%67.05%6.69%
Upgrade
Enterprise Value
3251-429
Upgrade
Last Close Price
0.951.151.754.7515.7530.30
Upgrade
PS Ratio
1.081.161.6147.55-31.86
Upgrade
PB Ratio
-3.60-0.76-5.871.651.493.19
Upgrade
P/TBV Ratio
---1.781.553.75
Upgrade
EV/Sales Ratio
5.500.930.30--29.48
Upgrade
Debt / Equity Ratio
-0.38-0.38-3.100.880.652.31
Upgrade
Asset Turnover
0.650.650.280.01-0.02
Upgrade
Quick Ratio
0.270.270.801.533.140.98
Upgrade
Current Ratio
0.340.340.921.843.361.07
Upgrade
Return on Equity (ROE)
---522.50%-234.65%-193.25%-393.27%
Upgrade
Return on Assets (ROA)
-101.93%-101.93%-47.23%-53.74%-44.65%-31.14%
Upgrade
Return on Capital (ROIC)
---111.58%-82.36%-54.64%-47.49%
Upgrade
Earnings Yield
-40.25%-191.39%-168.24%-190.35%-83.08%-85.36%
Upgrade
FCF Yield
-33.18%-157.80%-164.38%-126.56%-64.63%-88.32%
Upgrade
Buyback Yield / Dilution
-145.18%-145.18%-79.45%-117.18%-173.03%-219.93%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q